NCK1 and central nervous system cancer: Silencing of NCK1-AS1 might inhibit the proliferation, invasion, migration and resistance to death of glioma cells, and inhibit the metastasis of tumor in vivo through down-regulating TRIM24 and the following Wnt/β-catenin inactivation (Fig. 8).